Shorespan-007 will enroll approximately 300 patients with essential thrombocythemia and compare bomedemstat to the current standard of care, hydroxyurea.
Merck Initiates Shorespan-007 Clinical Trial of Bomedemstat for Essential Thrombocythemia
Leave a comment
